Streetbeat News

Stock Prices

ENVX

TD Cowen has downgraded Enovix's stock from Outperform to Market Perform, but increased its price target from $19 to $20. This has resulted in Enovix shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 7:35 pm

ARGX

A significant bullish stance has been taken on argenx (NASDAQ:ARGX) as evidenced by unusual options activity. The overall sentiment of these big-money traders is split between 58% bullish and 41% bearish. The price of ARGX is up 2.58% at $548.77. Citigroup, Raymond James, and Morgan Stanley have maintained their positive ratings on argenx, while HC Wainwright & Co. and Evercore ISI Group have downgraded their actions.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 7:34 pm

SPY

The market on close imbalance is leaning towards the sell-side with $136M. This indicates a potential downward pressure on stock prices at the close of the market.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 7:32 pm

VST

Morgan Stanley has maintained an Overweight rating on Vistra's stock and increased its price target from $32 to $33. This has led to a rise in Vistra's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 7:31 pm

ZBH

Zimmer Biomet Holdings Inc. (NYSE:ZBH) has seen its shares rise by 2.50% over the past three months. The company's total debt stands at $5.79 billion, with net debt at $5.46 billion after adjusting for cash equivalents. The debt ratio of the company is 0.27, indicating a moderate level of financial leverage. Debt is a crucial factor in a company's capital structure and can impact its growth and cash flow.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 7:15 pm

HOMB

Stephens analyst Matt Olney reiterated an Overweight rating on Home BancShares, Inc. (HOMB) and raised the price target to $27 from $26. The 2Q23 results were in line with consensus forecasts, driven by solid core fees and lower LLP expenses. However, NII was soft due to loan balance contraction and deposit remix headwinds. The 2023 Op EPS was increased from $1.97 to $1.99, while the 2024 EPS forecast was lowered from $1.80 to $1.78. The company is expected to remain conservative with new originations and forecasts modest loan growth contraction in 2H23.

Portfolio Pulse from Nabaparna Bhattacharya

July 21, 2023 | 7:08 pm

GPC

Genuine Parts Co (GPC) reported mixed Q2 2023 results, with sales growth of 5.6% Y/Y to $5.92 billion, missing the consensus of $5.96 billion, and adjusted EPS of $2.44 (+10.9% Y/Y) beating the consensus of $2.34. Following the results, analysts from Truist Securities, Stephens & Co., Wedbush, and JP Morgan lowered their price targets for GPC, while raising EPS estimates for 2023 and 2024.

Portfolio Pulse from Lekha Gupta

July 21, 2023 | 7:05 pm

LOW

A significant amount of unusual options activity has been detected for Lowe's Companies (NYSE:LOW), with a majority of investors taking a bearish stance. The targeted price range for Lowe's over the last 3 months is from $220.0 to $260.0. The current price of LOW is up 1.62% at $234.74. Argus Research and Truist Securities maintain a 'Buy' rating on Lowe's, with price targets of $260 and $249 respectively, while Wedbush maintains a 'Neutral' rating with a price target of $230.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 7:04 pm

TEAM

A significant amount of unusual options activity has been detected for Atlassian (NASDAQ:TEAM), with a bearish stance being taken by a majority of investors. Of the 11 strange trades detected, 45% were bullish and 54% were bearish. The total amount for puts was $349,082 and for calls was $194,130. Whales have been targeting a price range from $177.5 to $290.0 for Atlassian over the last 3 months. The current price of TEAM is down -0.6% at $174.59.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 7:04 pm

AXP

American Express Company (NYSE:AXP) reported better-than-expected Q2 earnings, but shares fell due to higher provisions for credit losses. The company's dividend yield is currently 1.36%. To earn $500 per month from AXP's dividends, an investment of around $441,176.47, or about 2,575 shares, is needed. However, the deteriorating consumer financial health in the U.S. could impact the company's performance.

Portfolio Pulse from AJ Fabino

July 21, 2023 | 7:03 pm